1
|
Supandi S, Wulandari MS, Samsul E, Azminah A, Purwoko RY, Herman H, Kuncoro H, Ibrahim A, Silfi Ambarwati NS, Rosmalena R, Azizah RN, Paramita S, Ahmad I. Dipeptidyl peptidase IV inhibition of phytocompounds from Artocarpus champeden (Lour.) Stokes: In silico molecular docking study and ADME-Tox prediction approach. J Adv Pharm Technol Res 2022; 13:207-215. [PMID: 35935696 PMCID: PMC9355056 DOI: 10.4103/japtr.japtr_376_22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2022] [Revised: 05/18/2022] [Accepted: 05/23/2022] [Indexed: 11/04/2022] Open
Abstract
The present study examines the potential activity prediction based on free binding energy (ΔG) and interaction confirmation of phytocompounds from Artocarpus champeden (Lour.) Stokes with macromolecule protein receptor of dipeptidyl peptidase IV (DPP-IV) using in silico molecular docking studies and physicochemical and pharmacokinetic properties (ADME-Tox) prediction approaches. The active subsites of the DPP-IV receptor macromolecule protein Protein Data Bank (ID: 1 × 70) were docked using Autodock v4.2.6 (100 docking runs). A grid box of 52 × 28 × 26 Å points spaced by 0.37 Å was centered on the active site of x = 40.926 Å; y = 50.522 Å; z = 35.031 Å. For ADME-Tox prediction, Swiss ADME online-based application programs were used. The results show that 12 pythocompounds from A. champeden have the potential as DPP-IV inhibitors based on ΔG value and interaction conformation. There are five pythocompounds with lower ΔG values and inhibition constants than the native ligand and seven pythocompounds with ΔG values and inhibition constants close to the native ligand. The 12 compounds form an interaction conformation at the active subsites of the DPP-IV receptor. At the same time, the results of the ADME-Tox prediction analysis showed that the 12 compounds had different physicochemical and pharmacokinetic properties.
Collapse
Affiliation(s)
- Supandi Supandi
- Department of Pharmaceutical Analysis, Faculty of Pharmacy and Science, Universitas Muhammadiyah Prof. Dr. HAMKA, South Jakarta, Indonesia
| | - Mesy Savira Wulandari
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Mulawarman, Samarinda, East Kalimantan, Indonesia
| | - Erwin Samsul
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Mulawarman, Samarinda, East Kalimantan, Indonesia
| | - Azminah Azminah
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Surabaya, Surabaya, Indonesia
| | - Reza Yuridian Purwoko
- Research Center for Pre-Clinical and Clinical Medicine, Indonesian Research and Innovation Agency, East Jakarta, Jakarta, Indonesia
| | - Herman Herman
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Mulawarman, Samarinda, East Kalimantan, Indonesia
| | - Hadi Kuncoro
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Mulawarman, Samarinda, East Kalimantan, Indonesia
| | - Arsyik Ibrahim
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Mulawarman, Samarinda, East Kalimantan, Indonesia
| | - Neneng Siti Silfi Ambarwati
- Department of Cosmetology, Engineering Faculty, Universitas Negeri Jakarta, East Jakarta, Jakarta, Indonesia
| | - Rosmalena Rosmalena
- Department of Medical Chemistry, Faculty of Medicine, Universitas Indonesia, South Jakarta, Indonesia
| | - Rizqi Nur Azizah
- Laboratory of Biopharmacy and Pharmacology, Faculty of Pharmacy, Universitas Muslim Indonesia, Makassar, South Sulawesi, Indonesia
| | - Swandari Paramita
- Department of Community Medicine, Faculty of Medicine, and Research Center of Natural Products from Tropical Rainforest, Universitas Mulawarman, Samarinda, East Kalimantan, Indonesia
| | - Islamudin Ahmad
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Mulawarman, Samarinda, East Kalimantan, Indonesia,Address for correspondence: Dr. Islamudin Ahmad, Jl. Kuaro Gn. Kelua, Samarinda 75119 East Kalimantan, Indonesia. E-mail:
| |
Collapse
|
2
|
Więckowska A, Szałaj N, Góral I, Bucki A, Latacz G, Kiec-Kononowicz K, Bautista-Aguilera ÒM, Romero A, Ramos E, Egea J, Farré Alíns V, González-Rodríguez Á, López-Muñoz F, Chioua M, Marco-Contelles J. In Vitro and In Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases. ACS Chem Neurosci 2020; 11:3793-3801. [PMID: 33143412 PMCID: PMC7677930 DOI: 10.1021/acschemneuro.0c00489] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
![]()
Herein we report in vitro metabolic stability
in human liver microsomes (HLMs), interactions with cytochrome P450
isoenzymes (CYP3A4, CYP2D6, and CYP2C9), and cytotoxicity analyses
on HEK-293, HepG2, Huh7, and WTIIB cell lines of our most recent multitarget
directed ligands PF9601N, ASS234, and contilisant. Based on these
results, we conclude that (1) PF9601N and contilisant are metabolically
stable in the HLM assay, in contrast to the very unstable ASS234;
(2) CYP3A4 activity was decreased by PF9601N at all the tested concentrations
and by ASS234 and contilisant only at the highest concentration; CYP2D6
activity was reduced by ASS234 at 1, 10, and 25 μM and by PF9601N
at 10 and 25 μM, whereas contilisant increased its activity
at the same concentrations; CYP2C9 was inhibited by the three compounds;
(3) contilisant did not affect cell viability in the widest range
of concentrations: up to 10 μM on HEK-293 cells, up to 30 μM
on Huh7 cells, up to 50 μM on HepG2 cells, and up to 30 or 100
μM on WTIIB cells. Based on these results, we selected contilisant
as a metabolically stable and nontoxic lead compound for further studies
in Alzheimer’s disease therapy.
Collapse
Affiliation(s)
- Anna Więckowska
- Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St., 30-688 Kraków, Poland
| | - Natalia Szałaj
- Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St., 30-688 Kraków, Poland
| | - Izabella Góral
- Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St., 30-688 Kraków, Poland
| | - Adam Bucki
- Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St., 30-688 Kraków, Poland
| | - Gniewomir Latacz
- Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St., 30-688 Kraków, Poland
| | | | - Òscar. M. Bautista-Aguilera
- Department of Organic Chemistry and Inorganic Chemistry, Alcalá University, 28805 Alcalá de Henares, Madrid, Spain
| | - Alejandro Romero
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain
| | - Eva Ramos
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain
| | - Javier Egea
- Health Research Institute, Clinical Pharmacology Service, University Hospital La Princesa, Autonomous University of Madrid, C/Diego de León 62, 28006 Madrid, Spain
- Institute Teófilo Hernando for Drug I+D, School of Medicine, Autonomous University of Madrid, 28029 Madrid, Spain
| | - Victor Farré Alíns
- Health Research Institute, Clinical Pharmacology Service, University Hospital La Princesa, Autonomous University of Madrid, C/Diego de León 62, 28006 Madrid, Spain
- Institute Teófilo Hernando for Drug I+D, School of Medicine, Autonomous University of Madrid, 28029 Madrid, Spain
| | - Águeda González-Rodríguez
- Health Research Institute, Clinical Pharmacology Service, University Hospital La Princesa, Autonomous University of Madrid, C/Diego de León 62, 28006 Madrid, Spain
- Institute Teófilo Hernando for Drug I+D, School of Medicine, Autonomous University of Madrid, 28029 Madrid, Spain
| | - Francisco López-Muñoz
- Faculty of Health Sciences, University Camilo José Cela, C/Castillo de Alarcón 49, 28692 Villanueva de la Cañada, Madrid, Spain
- Neuropsychopharmacology Unit, Hospital 12 de Octubre Research Institute (i+12), Avda Córdoba, s/n, 28041 Madrid, Spain
| | - Mourad Chioua
- Laboratory of Medicinal Chemistry (IQOG, CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain
| | - José Marco-Contelles
- Laboratory of Medicinal Chemistry (IQOG, CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain
| |
Collapse
|
3
|
Rácz A, Keserű GM. Large-scale evaluation of cytochrome P450 2C9 mediated drug interaction potential with machine learning-based consensus modeling. J Comput Aided Mol Des 2020; 34:831-9. [PMID: 32221780 DOI: 10.1007/s10822-020-00308-y] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2020] [Accepted: 03/09/2020] [Indexed: 11/17/2022]
Abstract
Cytochrome P450 (CYP) enzymes play an important role in the metabolism of xenobiotics. Since they are connected to drug interactions, screening for potential inhibitors is of utmost importance in drug discovery settings. Our study provides an extensive classification model for P450-drug interactions with one of the most prominent members, the 2C9 isoenzyme. Our model involved the largest set of 45,000 molecules ever used for developing prediction models. The models are based on three different types of descriptors, (a) typical one, two and three dimensional molecular descriptors, (b) chemical and pharmacophore fingerprints and (c) interaction fingerprints with docking scores. Two machine learning algorithms, the boosted tree and the multilayer feedforward of resilient backpropagation network were used and compared based on their performances. The models were validated both internally and using external validation sets. The results showed that the consensus voting technique with custom probability thresholds could provide promising results even in large-scale cases without any restrictions on the applicability domain. Our best model was capable to predict the 2C9 inhibitory activity with the area under the receiver operating characteristic curve (AUC) of 0.85 and 0.84 for the internal and the external test sets, respectively. The chemical space covered with the largest available dataset has reached its limit encompassing publicly available bioactivity data for the 2C9 isoenzyme.
Collapse
|
4
|
Ghiano DG, de la Iglesia A, Liu N, Tonge PJ, Morbidoni HR, Labadie GR. Antitubercular activity of 1,2,3-triazolyl fatty acid derivatives. Eur J Med Chem 2017; 125:842-52. [PMID: 27750201 DOI: 10.1016/j.ejmech.2016.09.086] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2016] [Revised: 09/24/2016] [Accepted: 09/26/2016] [Indexed: 12/27/2022]
Abstract
A collection of 1,2,3-triazoles unsaturated fatty acid mimics were efficiently synthesized by click chemistry. The 1,4-disubstituted analogs prepared covered different alkyl chain lengths and triazole positions. The compounds were subsequently tested against Mycobacterium tuberculosis, being most of them active with some of the analogs displaying activity at micromolar concentration. The most potent member of the series has the triazole moiety on the C-2 position with a carbon chain of eight or ten carbon atoms. The 1,5-isomers of the most active analog were significantly less active than the original isomer. The activity of the selected hit was assayed on several clinical MTB multi-drug resistant strains providing the same MIC.
Collapse
|